Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06146257
What this trial is testing

GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
GluBio Therapeutics Inc. 48
Testing effectiveness (Phase 2)UnknownNCT00112775
What this trial is testing

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02265731
What this trial is testing

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)+2 more
AbbVie 38
Testing effectiveness (Phase 2)Study completedNCT02193958
What this trial is testing

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
AMLCMMLMDS
Fujifilm Pharmaceuticals U.S.A., Inc. 55
Testing effectiveness (Phase 2)UnknownNCT04749355
What this trial is testing

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Who this might be right for
AML, AdultMDSRelapse/Recurrence+1 more
BioSight Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT00003758
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 60
Early research (Phase 1)Active Not RecruitingNCT03190278
What this trial is testing

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Cellectis S.A. 29
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Early research (Phase 1)Not Yet RecruitingNCT07737769
What this trial is testing

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
University of Michigan Rogel Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00512083
What this trial is testing

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid
Antisoma Research 70
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Early research (Phase 1)Active Not RecruitingNCT03927261
What this trial is testing

PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Precigen, Inc 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07449286
What this trial is testing

IFN-α in Relapse Prevention.

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686965
What this trial is testing

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Who this might be right for
Acute Myeloid Leukemia (AML)Maintenance TreatmentHematopoetic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 191
Testing effectiveness (Phase 2)Looking for participantsNCT06453902
What this trial is testing

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

Who this might be right for
Chronic Myeloid LeukemiaAccelerated Phase CML
Shenzhen TargetRx Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Early research (Phase 1)Study completedNCT02273102
What this trial is testing

Study of TCP-ATRA for Adult Patients With AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromesLeukemia
University of Miami 17
Early research (Phase 1)WithdrawnNCT02680951
What this trial is testing

Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Emory University
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Early research (Phase 1)Study completedNCT01961765
What this trial is testing

Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Massachusetts General Hospital 18
Next Page